These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35819935)

  • 1. Comprehensive evaluation of patterns of hypoglycemia unawareness (HUA) and glycemic variability (GV) in patients with fibrocalculous pancreatic diabetes (FCPD): A cross-sectional study from South India.
    Dasgupta R; Jebasingh FK; Anoop S; Seenivasan S; Kurian ME; Christina F; Varghese G; Christudoss P; Lijesh KU; David D; Chowdhury SD; Paul TV; Thomas N
    PLoS One; 2022; 17(7):e0270788. PubMed ID: 35819935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic variability in chronic calcific pancreatitis with diabetes mellitus and its possible determinants.
    Chowdhury AS; Palui R; Pramanik S; Mondal S
    Diabetes Metab Syndr; 2024 Aug; 18(8):103100. PubMed ID: 39142092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.
    Ghosh I; Mukhopadhyay P; Das K; Anne M B; Ali Mondal S; Basu M; Nargis T; Pandit K; Chakrabarti P; Ghosh S
    J Diabetes; 2021 Jun; 13(6):506-511. PubMed ID: 33247879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the clinical profile of fibrocalculous pancreatic diabetes and type 2 diabetes mellitus.
    Shivaprasad C; Anish K; Aiswarya Y; Atluri S; Rakesh B; Anupam B; Amit G
    Diabetes Metab Syndr; 2019; 13(2):1511-1516. PubMed ID: 31336514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring in subjects undergoing bariatric surgery: Diurnal and nocturnal glycemic patterns.
    Lupoli R; Lembo E; Ciciola P; Schiavo L; Pilone V; Capaldo B
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1954-1960. PubMed ID: 32807631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical spectrum of fibrocalculous pancreatic diabetes in north India.
    Mittal N; Mehrotra R; Agarwal G; Rajeswari ; Choudhuri G; Sikora S; Bhatia E
    Natl Med J India; 2002; 15(6):327-31. PubMed ID: 12540065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of children and adolescents with newly diagnosed Fibrocalculous pancreatitis diabetes (FCPD) and type 1 diabetes: A study from Eastern India.
    Sanyal D; Bhattacharjee K
    Diabetes Metab Syndr; 2022 Jul; 16(7):102527. PubMed ID: 35753293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of diabetic complications in fibrocalculous pancreatic diabetic patients and type 2 diabetic patients: a cross-sectional comparative study.
    Kanta Barman K; Padmanabhan M; Premalatha G; Deepa R; Rema M; Mohan V
    J Diabetes Complications; 2004; 18(5):264-70. PubMed ID: 15337499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of End-Organ Damage, Beta Cell Reserve, and Exocrine Pancreas Defect in Fibrocalculous Pancreatic Diabetes: An Eastern India Perspective.
    Anne B; Ghosh S; Ghosh I; Ray S; Chowdhury S; Dutta D
    Indian J Endocrinol Metab; 2019; 23(4):438-445. PubMed ID: 31741903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of insulin sensitivity and secretion in patients with fibrocalculous pancreatic diabetes.
    Aiswarya Y; Shivaprasad C; Anish K; Sridevi A; Anupam B; Amit G
    Diabetes Metab Syndr Obes; 2019; 12():779-788. PubMed ID: 31190936
    [No Abstract]   [Full Text] [Related]  

  • 13. The Clinical Spectrum of Fibrocalculous Pancreatic Diabetes in Kashmir Valley and Comparative Study of the Clinical Profile of Fibrocalculous Pancreatic Diabetes and Type 2 Diabetes Mellitus.
    Bhat JA; Bhat MH; Misgar RA; Bashir MI; Wani AI; Masoodi SR; Ashraf H; Sood M
    Indian J Endocrinol Metab; 2019; 23(5):580-584. PubMed ID: 31803601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy.
    Salehi M; Gastaldelli A; DeFronzo R
    Metabolism; 2022 Jun; 131():155199. PubMed ID: 35390439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia.
    Lobato CB; Pereira SS; Guimarães M; Hartmann B; Wewer Albrechtsen NJ; Hilsted L; Holst JJ; Nora M; Monteiro MP
    Front Endocrinol (Lausanne); 2020; 11():608248. PubMed ID: 33424773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia unawareness in IDDM.
    Mokan M; Mitrakou A; Veneman T; Ryan C; Korytkowski M; Cryer P; Gerich J
    Diabetes Care; 1994 Dec; 17(12):1397-403. PubMed ID: 7882808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-abdominal fat estimation by bio-electrical impedance analysis in patients with fibrocalculous pancreatic diabetes compared with BMI matched type 2 diabetic subjects and healthy controls.
    Shivaprasad C; Gautham K; Palani P; Gupta S; Shah K
    Diabetes Metab Syndr; 2020; 14(5):789-795. PubMed ID: 32531743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic dysfunction in non-insulin-dependent diabetes mellitus and fibrocalculous pancreatic diabetes in south India.
    Mohan V; Sastry NG; Premalatha G
    Diabet Med; 1996 Dec; 13(12):1038-43. PubMed ID: 8973885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketosis resistance in fibrocalculous pancreatic diabetes: II. Hepatic ketogenesis after oral medium-chain triglycerides.
    Yajnik CS; Sardesai BS; Bhat DS; Naik SS; Raut KN; Shelgikar KM; Orskov H; Alberti KG; Hockaday TD
    Metabolism; 1997 Jan; 46(1):1-4. PubMed ID: 9005960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.